These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


326 related items for PubMed ID: 19531173

  • 21. Glycopyrrolate for chronic drooling in children.
    Eiland LS.
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [Abstract] [Full Text] [Related]

  • 22. The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy.
    Jongerius PH, van Hulst K, van den Hoogen FJ, Rotteveel JJ.
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):351-3. PubMed ID: 16131993
    [No Abstract] [Full Text] [Related]

  • 23. Drooling of saliva in children with cerebral palsy-etiology, prevalence, and relationship to salivary flow rate in an Indian population.
    Hegde AM, Pani SC.
    Spec Care Dentist; 2009 Sep; 29(4):163-8. PubMed ID: 19573043
    [Abstract] [Full Text] [Related]

  • 24. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH, Aburahma SK, Khader YS.
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [Abstract] [Full Text] [Related]

  • 25. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N, Penn C.
    Int J Lang Commun Disord; 2011 Jan; 46(5):550-63. PubMed ID: 21899672
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [Abstract] [Full Text] [Related]

  • 30. Management options for the drooling patient.
    Crysdale WS.
    Ear Nose Throat J; 1989 Nov; 68(11):820, 825-6, 829-30. PubMed ID: 2612390
    [Abstract] [Full Text] [Related]

  • 31. Drooling in children with cerebral palsy.
    Van De Heyning PH, Marquet JF, Creten WL.
    Acta Otorhinolaryngol Belg; 1980 Nov; 34(6):691-705. PubMed ID: 7223419
    [No Abstract] [Full Text] [Related]

  • 32. Use of trihexyphenidyl in children with cerebral palsy.
    Carranza-del Rio J, Clegg NJ, Moore A, Delgado MR.
    Pediatr Neurol; 2011 Mar; 44(3):202-6. PubMed ID: 21310336
    [Abstract] [Full Text] [Related]

  • 33. Management of drooling in children with cerebral palsy: A French survey.
    Chaléat-Valayer E, Porte M, Buchet-Poyau K, Roumenoff-Turcant F, D'Anjou MC, Boulay C, Bernard JC, Touzet S.
    Eur J Paediatr Neurol; 2016 Jul; 20(4):524-31. PubMed ID: 27155820
    [Abstract] [Full Text] [Related]

  • 34. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
    Fuster Torres MA, Berini Aytés L, Gay Escoda C.
    Med Oral Patol Oral Cir Bucal; 2007 Nov 01; 12(7):E511-7. PubMed ID: 17978775
    [Abstract] [Full Text] [Related]

  • 35. Surgical management of drooling: clinical and caregiver satisfaction outcomes.
    Stamataki S, Behar P, Brodsky L.
    Int J Pediatr Otorhinolaryngol; 2008 Dec 01; 72(12):1801-5. PubMed ID: 18848362
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Drooling in neuropediatric patients].
    Steffen A, Ortfeld S, Schönweiler R.
    Klin Padiatr; 2011 Jan 01; 223(1):5-9. PubMed ID: 21271513
    [Abstract] [Full Text] [Related]

  • 39. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy.
    Carr LJ.
    Dev Med Child Neurol; 2009 Sep 01; 51(9):687-8. PubMed ID: 19709139
    [No Abstract] [Full Text] [Related]

  • 40. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency.
    Molenaers G, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Desloovere K.
    Eur J Paediatr Neurol; 2009 Sep 01; 13(5):421-9. PubMed ID: 18977158
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.